The impact of anxiety level on the outcome of alopecia therapy in women
Background. Alopecia is a common dermatological condition associated with significant psychological stress, particularly in women. Anxiety frequently accompanies this condition, negatively impacting quality of life and treatment outcomes. Aim. To assess anxiety levels in women with androgenetic a...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ZAO "Consilium Medicum"
2025-01-01
|
| Series: | Consilium Medicum |
| Subjects: | |
| Online Access: | https://consilium.orscience.ru/2075-1753/article/viewFile/677158/202365 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background. Alopecia is a common dermatological condition associated with significant psychological stress, particularly in women. Anxiety frequently accompanies this condition, negatively impacting quality of life and treatment outcomes.
Aim. To assess anxiety levels in women with androgenetic and alopecia areata and their dynamics during therapy with the anxiolytic drug temgikoluril (Adaptol).
Materials and methods. The study included 42 patients in the main group and 40 in the control group. Anxiety levels were assessed using the Hospital Anxiety and Depression Scale-Anxiety Subscale at baseline, 6 weeks, and 12 weeks. The main group received temgikoluril in addition to standard alopecia therapy.
Results. In the main group, anxiety levels significantly decreased at 6 weeks and continued to decline at 12 weeks. In the control group, anxiety reduction was less pronounced. Both groups showed positive trichological dynamics, but the main group reported better emotional state and reduced focus on hair loss issues.
Conclusion. Anxiolytic therapy with temgikoluril significantly reduces anxiety levels in patients with alopecia, improving treatment satisfaction, which highlights the importance of a comprehensive approach to alopecia management. |
|---|---|
| ISSN: | 2075-1753 2542-2170 |